{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:16:45Z","timestamp":1770909405690,"version":"3.50.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:p>Acid sphingomyelinase deficiency (ASMD; Niemann-Pick disease type A and B) is a lysosomal storage disorder characterized by abnormal intracellular sphingomyelin (SM) accumulation. Prominent liver involvement results in hepatomegaly, fibrosis\/cirrhosis, abnormal liver chemistries, and a proatherogenic lipid profile. Olipudase alfa (recombinant human ASM) is in clinical development as an investigational enzyme replacement therapy for the non-neurological manifestations of ASMD. In a phase 1b study conducted to evaluate the safety and tolerability of within-patient dose escalation with olipudase alfa, measurement of SM levels in liver biopsies was used as a pharmacodynamic biomarker of substrate burden. Five adult patients with non neuronopathic ASMD received escalating doses of olipudase alfa every 2 weeks for 26 weeks. Liver biopsies obtained at baseline and 26 weeks after treatment were evaluated for SM storage by histomorphometric analysis, biochemistry, and electron microscopy. Biopsies were also assessed for inflammation and fibrosis, and for the association of SM levels with liver volume, liver function tests, and lipid profiles. At baseline, SM storage present in Kupffer cells and hepatocytes ranged from 9.8% to 53.8% of the microscopic field. After 26 weeks of treatment, statistically significant reductions in SM (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001) measured by morphometry were seen in 4 patients with evaluable liver biopsies. The 26-week biopsy of the fifth patient was insufficient for morphometric quantitation. Posttreatment SM levels ranged from 1.2% to 9.5% of the microscopic field, corresponding to an 84% to 92% relative reduction from baseline. Improvements in liver volume, liver function tests, and lipid profiles were also observed. This study illustrates the utility of SM assessment by liver biopsy as a pharmacodynamic biomarker of disease burden in these patients.<\/jats:p>","DOI":"10.1097\/pas.0000000000000659","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T16:10:51Z","timestamp":1466784651000},"page":"1232-1242","source":"Crossref","is-referenced-by-count":27,"title":["Clearance of Hepatic Sphingomyelin by Olipudase Alfa Is Associated With Improvement in Lipid Profiles in Acid Sphingomyelinase Deficiency"],"prefix":"10.1097","volume":"40","author":[{"given":"Beth L.","family":"Thurberg","sequence":"first","affiliation":[{"name":"Pathology"},{"name":"Clinical Development, Sanofi Genzyme, Cambridge"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa P.","family":"Wasserstein","sequence":"additional","affiliation":[{"name":"Division of Pediatric Genetic Medicine, The Children\u2019s Hospital at Montefiore, Bronx"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon A.","family":"Jones","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, CMFT, University of Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[{"name":"Division of Liver Diseases, Mount Sinai School of Medicine, NY, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald F.","family":"Cox","sequence":"additional","affiliation":[{"name":"Clinical Development, Sanofi Genzyme, Cambridge"},{"name":"Division of Genetics, Children\u2019s Hospital Boston"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cristina","family":"Puga","sequence":"additional","affiliation":[{"name":"Clinical Development, Sanofi Genzyme, Cambridge"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gim.2013.4","article-title":"Morbidity and mortality in type B Niemann-Pick disease","volume":"15","author":"McGovern","year":"2013","journal-title":"Genet Med"},{"key":"R3-20230922","first-page":"117","article-title":"Cirrhosis and liver failure: expanding phenotype of acid sphingomyelinase-deficient Niemann-Pick disease in adulthood","volume":"15","author":"Lidove","year":"2015","journal-title":"JIMD Rep"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrg2481","article-title":"Plasma lipoproteins: genetic influences and clinical implications","volume":"10","author":"Hegele","year":"2009","journal-title":"Nat Rev Genet"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIRCRESAHA.114.300632","article-title":"Regulation of high-density lipoprotein metabolism","volume":"114","author":"Rye","year":"2014","journal-title":"Circ Res"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0005-2760(83)90218-7","article-title":"Biochemical studies in Niemann-Pick disease: major sphingolipids of liver and spleen","volume":"750","author":"Vanier","year":"1983","journal-title":"Biochim Biophys Acta"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1542\/peds.2004-0887","article-title":"The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study","volume":"114","author":"Wasserstein","year":"2004","journal-title":"Pediatrics"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1542\/peds.2007-3016","article-title":"A prospective, cross-sectional survey study of the natural history of Niemann-Pick Disease Type B","volume":"122","author":"McGovern","year":"2008","journal-title":"Pediatrics"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ymgme.2012.06.015","article-title":"Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease sprectrum and natural course in attenuated patients","volume":"107","author":"Hollak","year":"2012","journal-title":"Mol Genet Metab"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jmg.27.8.499","article-title":"Very low levels of high density lipoprotein cholesterol in four sibs of a family with non-neuropathic Niemann-Pick disease and sea-blue histiocytosis","volume":"27","author":"Viana","year":"1990","journal-title":"J Med Genet"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2559.2006.02355.x","article-title":"Pulmonary involvement by Niemann-Pick disease. A report of six cases","volume":"48","author":"Nicholson","year":"2006","journal-title":"Histopathology"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1161\/01.ATV.20.12.2614","article-title":"Plasma sphingomyelin level as a risk factor for coronary artery disease","volume":"20","author":"Jiang","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/aje\/kwj140","article-title":"Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis","volume":"163","author":"Nelson","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MCO.0b013e328028fda3","article-title":"Sphingolipids: major regulators of lipid metabolism","volume":"10","author":"Worgall","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1161\/ATVBAHA.113.301736","article-title":"C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study","volume":"33","author":"Van Wijk","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/bph.12616","article-title":"C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells","volume":"171","author":"Bian","year":"2014","journal-title":"Br J Pharmacol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1053\/euhj.2000.2148","article-title":"Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality","volume":"21","author":"Erikssen","year":"2000","journal-title":"Eur Heart J"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0195-668X(02)00741-8","article-title":"Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality","volume":"24","author":"Natali","year":"2003","journal-title":"Eur Heart J"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpeds.2004.02.048","article-title":"Lipid abnormalities in children with types A and B Niemann-Pick Disease","volume":"145","author":"McGovern","year":"2004","journal-title":"J Pediatr"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10545-006-0226-y","article-title":"Acid sphingomyelinase deficiency: cardiac dysfunction and characteristic findings of the coronary arteries","volume":"29","author":"Ishii","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the fabry kidney is cleared from multiple cell types after enzyme replacement therapy","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney Int"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.0022-202X.2004.22425.x","article-title":"Monitoring the three year efficacy of enzyme replacement therapy in fabry disease by repeated skin biopsies","volume":"122","author":"Thurberg","year":"2004","journal-title":"J Invest Dermatol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement for pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab Invest"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1161\/CIRCULATIONAHA.108.841494","article-title":"Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy","volume":"118","author":"Thurberg","year":"2009","journal-title":"Circulation"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/PAS.0b013e31825793ff","article-title":"Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick Disease Type B)","volume":"36","author":"Thurberg","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/gim.2015.24","article-title":"Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency)","volume":"18","author":"McGovern","year":"2016","journal-title":"Genet Med"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgme.2015.05.013","article-title":"Successful within-patient dose escalation oflipudase alfa in acid sphingomyelinase deficiency","volume":"116","author":"Wasserstein","year":"2015","journal-title":"Mol Genet Metab"},{"key":"R29-20230922","first-page":"620","article-title":"Optimization of a histopathological biomarker for sphingomyelin accumulation in Niemann-Pick B Disease","volume":"60","author":"Taksir","year":"2012","journal-title":"J Histochem Biochem"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/002215540505300108","article-title":"High resolution light microscopy (HRLM) and digital analysis of Pompe disease pathology","volume":"53","author":"Lynch","year":"2005","journal-title":"J Histochem Cytochem"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/hep.1840060430","article-title":"Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver","volume":"6","author":"Bouwens","year":"1986","journal-title":"Hepatology"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.41.1","article-title":"Development and differentiation of macrophages and related cells: historical review and current concepts","volume":"41","author":"Takahashi","year":"2001","journal-title":"J Clin Exp Hematol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1210\/jc.2012-2185","article-title":"Approach to the patient with extremely low HDL-cholesterol","volume":"97","author":"Rader","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbalip.2014.07.015","article-title":"HDL and atherosclerosis: insights from inherited HDL disorders","volume":"1851","author":"Calabresi","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0016-5085(81)90732-0","article-title":"Functional implications of liver cell heterogeneity","volume":"80","author":"Gumucio","year":"1981","journal-title":"Gastroenterology"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/hep.510310201","article-title":"Oxygen: modulator of metabolic zonation and disease of the liver","volume":"31","author":"Jungermann","year":"2000","journal-title":"Hepatology"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bbrc.2014.10.017","article-title":"An in vitro hepatic zonation model with a continuous oxygen gradient in a microdevice","volume":"453","author":"Sato","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1194\/jlr.M500357-JLR200","article-title":"Absorption and lipoprotein transport of sphingomyelin","volume":"47","author":"Nilsson","year":"2006","journal-title":"J Lipid Res"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"19152","DOI":"10.1074\/jbc.271.32.19152","article-title":"Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding","volume":"32","author":"Bolin","year":"1996","journal-title":"J Biol Chem"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1194\/jlr.M500011-JLR200","article-title":"ESI-MS quantitation of increased SM in Niemann-Pick disease type B HDL","volume":"46","author":"Lee","year":"2005","journal-title":"J Lipid Res"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1194\/jlr.M500487-JLR200","article-title":"Increased SM content impairs HDL biogenesis and maturation in human Niemann-Pick disease type B","volume":"47","author":"Lee","year":"2006","journal-title":"J Lipid Res"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1388-1981(02)00365-7","article-title":"Effects of sphingomyelin on apolipoprotein E and lipoprotein lipase-mediated cell uptake of lipid particles","volume":"1631","author":"Morita","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.bbalip.2012.02.007","article-title":"Regulation of plasma cholesterol esterification by sphingomyelin: Effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity","volume":"1821","author":"Subbaiah","year":"2012","journal-title":"Biochim BioPhys Acta"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2796.2006.01647.x","article-title":"The rationale for using apoA-I as a clinical marker of cardiovascular risk","volume":"259","author":"Barter","year":"2006","journal-title":"J Int Med"},{"key":"R48-20230922","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-2275(20)34210-3","article-title":"Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions","volume":"39","author":"Arimoto","year":"1998","journal-title":"J Lipid Res"},{"key":"R49-20230922","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.atherosclerosis.2005.12.029","article-title":"Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in apoE knockout mice","volume":"189","author":"Park","year":"2006","journal-title":"Atherosclerosis"},{"key":"R50-20230922","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-7075-3-5","article-title":"Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease","volume":"3","author":"Schlitt","year":"2006","journal-title":"Nutr Metab (Lond)"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201609000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:23:26Z","timestamp":1695421406000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201609000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000659","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}